• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[静脉血栓栓塞的预防——对象、时机及方法?]

[Prevention of venous thromboembolism--in whom, when and how?].

作者信息

Biasiutti F D, Lämmle B

机构信息

Hämatologisches Zentrallabor der Universität, Inselspital, Bern.

出版信息

Ther Umsch. 1994 Oct;51(10):663-70.

PMID:7839322
Abstract

Venous thromboembolic diseases are of major importance with respect to morbidity and mortality. Therefore, efficient prophylaxis is essential. Indication for thromboprophylaxis has to be made individually: In high risk situations, especially in orthopedic surgery, every patient should receive medical prophylaxis, e.g. with heparin, in addition to other preventive measures such as the wearing of elastic stockings or physiotherapy until full mobilization. For high-risk patients having a history of recurrent venous thromboembolism or which are suffering from a thrombogenic disease (e.g. myeloproliferative disorder, especially polycythemia vera, paroxysmal nocturnal hemoglobinuria, systemic lupus erythematosus, homocystinuria) or a hereditary thrombophilia (e.g. deficiency of antithrombin III, protein S, protein C or APC resistance), prophylactic measures should be more generally applied. In these patients, risk factors (e.g. oral contraceptive medication) or risk situations (e.g. long-distance travelling by car or airplane) have to be avoided whenever possible. In inevitable risk situations (e.g. perioperative or peripartal period) prophylaxis is mandatory. It is generally limited to the period of elevated thrombogenic risk and is often effected by application of a low molecular weight heparin. Patients with a history of recurrent thromboembolic events despite elimination of all avoidable risk factors should get a lifelong prophylaxis, usually with oral anticoagulants.

摘要

静脉血栓栓塞性疾病在发病率和死亡率方面具有重要意义。因此,有效的预防至关重要。血栓预防的指征必须个体化确定:在高风险情况下,尤其是在骨科手术中,除了其他预防措施,如穿着弹力袜或进行物理治疗直至完全活动自如外,每位患者都应接受药物预防,例如使用肝素。对于有复发性静脉血栓栓塞病史或患有血栓形成性疾病(如骨髓增殖性疾病,尤其是真性红细胞增多症、阵发性夜间血红蛋白尿、系统性红斑狼疮、高胱氨酸尿症)或遗传性血栓形成倾向(如抗凝血酶III、蛋白S、蛋白C缺乏或APC抵抗)的高风险患者,应更广泛地应用预防措施。在这些患者中,应尽可能避免危险因素(如口服避孕药)或风险情况(如长时间乘车或乘飞机旅行)。在不可避免的风险情况(如围手术期或围产期),预防是强制性的。通常仅限于血栓形成风险升高的时期,且常通过应用低分子量肝素实现。尽管消除了所有可避免的危险因素,但仍有复发性血栓栓塞事件病史的患者应接受终身预防,通常使用口服抗凝剂。

相似文献

1
[Prevention of venous thromboembolism--in whom, when and how?].[静脉血栓栓塞的预防——对象、时机及方法?]
Ther Umsch. 1994 Oct;51(10):663-70.
2
A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.一项关于新型第二代低分子肝素(苄丙酮香豆素钠)和普通肝素预防术后静脉血栓栓塞的双盲随机对照试验。苄丙酮香豆素钠评估组。
Thromb Haemost. 2000 Apr;83(4):523-9.
3
Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.静脉血栓栓塞:结直肠手术患者的风险与预防综述
Dis Colon Rectum. 2006 Oct;49(10):1620-8. doi: 10.1007/s10350-006-0693-0.
4
[Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].[遗传性血栓形成倾向对口服避孕药所致血栓形成风险的意义]
Zentralbl Gynakol. 1996;118(5):262-70.
5
[Effect of anesthesia and anticoagulant prophylaxis on the occurrence of postoperative thromboembolic complications in orthopedic patients].[麻醉与抗凝预防对骨科患者术后血栓栓塞并发症发生情况的影响]
Anesteziol Reanimatol. 2006 Mar-Apr(2):35-8.
6
Perioperative management of long-term anticoagulation.长期抗凝治疗的围手术期管理
Semin Thromb Hemost. 1998;24 Suppl 1:77-83.
7
[Evaluating the origin of thrombophilia: indications and implementation].[评估血栓形成倾向的起源:指征与实施]
Ther Umsch. 1992 Dec;49(12):850-8.
8
[Thromboembolism--genetic and acquired risk factors].[血栓栓塞——遗传和后天风险因素]
Acta Med Austriaca. 1999;26(2):37-40.
9
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.深静脉血栓形成的临床病程。对528例有症状患者的前瞻性长期随访。
Haematologica. 1997 Jul-Aug;82(4):423-8.
10
[Medical principles of thromboembolism prevention].[血栓栓塞预防的医学原理]
Langenbecks Arch Chir Suppl Kongressbd. 1998;115:767-78.

引用本文的文献

1
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.胱硫醚β-合酶缺乏症的诊断与管理指南。
J Inherit Metab Dis. 2017 Jan;40(1):49-74. doi: 10.1007/s10545-016-9979-0. Epub 2016 Oct 24.